Diamond Power Infrastructure Limited

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, CUMMINSIND.BO has a market cap of 1.5T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while CUMMINSIND.BO trades at ₹5,238.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas CUMMINSIND.BO's P/E ratio is 64.61. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to CUMMINSIND.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to CUMMINSIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check CUMMINSIND.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, CUMMINSIND.NS has a market cap of 1.5T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while CUMMINSIND.NS trades at ₹5,238.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas CUMMINSIND.NS's P/E ratio is 64.66. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to CUMMINSIND.NS's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to CUMMINSIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check CUMMINSIND.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, BHEL.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while BHEL.NS trades at ₹401.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas BHEL.NS's P/E ratio is 87.06. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to BHEL.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to BHEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check BHEL.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, BHEL.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while BHEL.BO trades at ₹401.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas BHEL.BO's P/E ratio is 87.05. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to BHEL.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to BHEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check BHEL.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ABB.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ABB.NS trades at ₹6,387.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ABB.NS's P/E ratio is 86.75. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ABB.NS's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to ABB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ABB.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ABB.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ABB.BO trades at ₹6,382.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ABB.BO's P/E ratio is 76.55. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ABB.BO's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to ABB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ABB.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SIEMENS.NS has a market cap of 1.3T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SIEMENS.NS trades at ₹3,605.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SIEMENS.NS's P/E ratio is 76.07. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SIEMENS.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to SIEMENS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SIEMENS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SIEMENS.BO has a market cap of 1.3T. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SIEMENS.BO trades at ₹3,604.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SIEMENS.BO's P/E ratio is 76.10. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SIEMENS.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to SIEMENS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SIEMENS.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, THERMAX.NS has a market cap of 512B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while THERMAX.NS trades at ₹4,545.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas THERMAX.NS's P/E ratio is 70.93. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to THERMAX.NS's ROE of +0.14%. Regarding short-term risk, DIACABS.BO is less volatile compared to THERMAX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check THERMAX.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, THERMAX.BO has a market cap of 510.7B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while THERMAX.BO trades at ₹4,533.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas THERMAX.BO's P/E ratio is 75.07. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to THERMAX.BO's ROE of +0.14%. Regarding short-term risk, DIACABS.BO is less volatile compared to THERMAX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check THERMAX.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, VOLTAS.NS has a market cap of 432.3B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while VOLTAS.NS trades at ₹1,306.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas VOLTAS.NS's P/E ratio is 86.52. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to VOLTAS.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.BO is more volatile compared to VOLTAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VOLTAS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, VOLTAS.BO has a market cap of 432B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while VOLTAS.BO trades at ₹1,305.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas VOLTAS.BO's P/E ratio is 85.89. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to VOLTAS.BO's ROE of +0.08%. Regarding short-term risk, DIACABS.BO is more volatile compared to VOLTAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VOLTAS.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, GET&D.NS has a market cap of 397.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while GET&D.NS trades at ₹1,552.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas GET&D.NS's P/E ratio is 100.73. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to GET&D.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.BO is more volatile compared to GET&D.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GET&D.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, AIAENG.BO has a market cap of 364.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while AIAENG.BO trades at ₹3,906.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas AIAENG.BO's P/E ratio is 31.35. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to AIAENG.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to AIAENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check AIAENG.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, AIAENG.NS has a market cap of 364.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while AIAENG.NS trades at ₹3,905.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas AIAENG.NS's P/E ratio is 31.42. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to AIAENG.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to AIAENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check AIAENG.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, BLUESTARCO.NS has a market cap of 341.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while BLUESTARCO.NS trades at ₹1,661.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas BLUESTARCO.NS's P/E ratio is 64.56. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to BLUESTARCO.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to BLUESTARCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check BLUESTARCO.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SCHNEIDER.NS has a market cap of 314.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SCHNEIDER.NS trades at ₹1,316.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SCHNEIDER.NS's P/E ratio is 128.86. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SCHNEIDER.NS's ROE of +0.45%. Regarding short-term risk, DIACABS.BO is more volatile compared to SCHNEIDER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SCHNEIDER.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KAYNES.NS has a market cap of 292.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KAYNES.NS trades at ₹4,364.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KAYNES.NS's P/E ratio is 73.91. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KAYNES.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is more volatile compared to KAYNES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KAYNES.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KAYNES.BO has a market cap of 292.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KAYNES.BO trades at ₹4,363.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KAYNES.BO's P/E ratio is 73.88. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KAYNES.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.BO is more volatile compared to KAYNES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KAYNES.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KIRLOSENG.BO has a market cap of 241.4B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KIRLOSENG.BO trades at ₹1,660.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KIRLOSENG.BO's P/E ratio is 44.50. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KIRLOSENG.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLOSENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSENG.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KIRLOSENG.NS has a market cap of 241.3B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KIRLOSENG.NS trades at ₹1,660.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KIRLOSENG.NS's P/E ratio is 44.46. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KIRLOSENG.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLOSENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSENG.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, MTARTECH.NS has a market cap of 200.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while MTARTECH.NS trades at ₹6,520.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas MTARTECH.NS's P/E ratio is 314.98. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to MTARTECH.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is less volatile compared to MTARTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check MTARTECH.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, MTARTECH.BO has a market cap of 200.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while MTARTECH.BO trades at ₹6,506.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas MTARTECH.BO's P/E ratio is 314.18. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to MTARTECH.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is less volatile compared to MTARTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check MTARTECH.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LAXMIMACH.BO has a market cap of 185.2B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LAXMIMACH.BO trades at ₹17,338.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LAXMIMACH.BO's P/E ratio is 63.86. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LAXMIMACH.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to LAXMIMACH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LAXMIMACH.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LAXMIMACH.NS has a market cap of 185.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LAXMIMACH.NS trades at ₹17,324.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LAXMIMACH.NS's P/E ratio is 63.45. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LAXMIMACH.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to LAXMIMACH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LAXMIMACH.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TRITURBINE.BO has a market cap of 185.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TRITURBINE.BO trades at ₹582.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TRITURBINE.BO's P/E ratio is 54.05. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TRITURBINE.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to TRITURBINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TRITURBINE.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TRITURBINE.NS has a market cap of 185B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TRITURBINE.NS trades at ₹582.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TRITURBINE.NS's P/E ratio is 54.09. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TRITURBINE.NS's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is more volatile compared to TRITURBINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TRITURBINE.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TDPOWERSYS.NS has a market cap of 184.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TDPOWERSYS.NS trades at ₹1,178.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TDPOWERSYS.NS's P/E ratio is 84.01. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TDPOWERSYS.NS's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is less volatile compared to TDPOWERSYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check TDPOWERSYS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TDPOWERSYS.BO has a market cap of 184.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TDPOWERSYS.BO trades at ₹1,178.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TDPOWERSYS.BO's P/E ratio is 83.99. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TDPOWERSYS.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to TDPOWERSYS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TDPOWERSYS.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ELGIEQUIP.BO has a market cap of 171B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ELGIEQUIP.BO trades at ₹542.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ELGIEQUIP.BO's P/E ratio is 42.37. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ELGIEQUIP.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELGIEQUIP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELGIEQUIP.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ELGIEQUIP.NS has a market cap of 170.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ELGIEQUIP.NS trades at ₹541.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ELGIEQUIP.NS's P/E ratio is 42.32. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ELGIEQUIP.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELGIEQUIP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELGIEQUIP.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, JYOTICNC.NS has a market cap of 169.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while JYOTICNC.NS trades at ₹746.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas JYOTICNC.NS's P/E ratio is 47.98. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to JYOTICNC.NS's ROE of +0.21%. Regarding short-term risk, DIACABS.BO is more volatile compared to JYOTICNC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check JYOTICNC.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LMW.BO has a market cap of 158.7B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LMW.BO trades at ₹14,851.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LMW.BO's P/E ratio is 137.81. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LMW.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to LMW.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LMW.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LMW.NS has a market cap of 158.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LMW.NS trades at ₹14,847.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LMW.NS's P/E ratio is 137.73. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LMW.NS's ROE of +0.04%. Regarding short-term risk, DIACABS.BO is more volatile compared to LMW.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LMW.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KSB.NS has a market cap of 153.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KSB.NS trades at ₹884.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KSB.NS's P/E ratio is 59.64. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KSB.NS's ROE of +0.00%. Regarding short-term risk, DIACABS.BO is more volatile compared to KSB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KSB.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KSB.BO has a market cap of 153.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KSB.BO trades at ₹883.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KSB.BO's P/E ratio is 59.48. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KSB.BO's ROE of +0.00%. Regarding short-term risk, DIACABS.BO is more volatile compared to KSB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KSB.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, AZAD.NS has a market cap of 140.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while AZAD.NS trades at ₹2,180.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas AZAD.NS's P/E ratio is 113.43. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to AZAD.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is less volatile compared to AZAD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check AZAD.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, INGERRAND.NS has a market cap of 139.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while INGERRAND.NS trades at ₹4,432.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas INGERRAND.NS's P/E ratio is 54.11. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to INGERRAND.NS's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to INGERRAND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check INGERRAND.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, INGERRAND.BO has a market cap of 139.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while INGERRAND.BO trades at ₹4,429.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas INGERRAND.BO's P/E ratio is 52.89. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to INGERRAND.BO's ROE of +0.41%. Regarding short-term risk, DIACABS.BO is more volatile compared to INGERRAND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check INGERRAND.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KIRLOSBROS.NS has a market cap of 132.4B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KIRLOSBROS.NS trades at ₹1,667.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KIRLOSBROS.NS's P/E ratio is 33.19. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KIRLOSBROS.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLOSBROS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSBROS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KIRLOSBROS.BO has a market cap of 132.4B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KIRLOSBROS.BO trades at ₹1,666.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KIRLOSBROS.BO's P/E ratio is 33.72. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KIRLOSBROS.BO's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLOSBROS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLOSBROS.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, INOXINDIA.NS has a market cap of 132.4B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while INOXINDIA.NS trades at ₹1,458.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas INOXINDIA.NS's P/E ratio is 53.44. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to INOXINDIA.NS's ROE of +0.29%. Regarding short-term risk, DIACABS.BO is more volatile compared to INOXINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check INOXINDIA.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TEGA.BO has a market cap of 122.2B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TEGA.BO trades at ₹1,626.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TEGA.BO's P/E ratio is 54.05. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TEGA.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEGA.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TEGA.NS has a market cap of 121.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TEGA.NS trades at ₹1,622.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TEGA.NS's P/E ratio is 53.94. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TEGA.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEGA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEGA.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ELECON.BO has a market cap of 118.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ELECON.BO trades at ₹529.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ELECON.BO's P/E ratio is 34.84. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ELECON.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELECON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELECON.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ELECON.NS has a market cap of 118.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ELECON.NS trades at ₹529.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ELECON.NS's P/E ratio is 34.77. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ELECON.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to ELECON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ELECON.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KIRLPNU.NS has a market cap of 98.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KIRLPNU.NS trades at ₹1,522.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KIRLPNU.NS's P/E ratio is 38.71. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KIRLPNU.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLPNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLPNU.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KIRLPNU.BO has a market cap of 98.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KIRLPNU.BO trades at ₹1,521.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KIRLPNU.BO's P/E ratio is 38.59. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KIRLPNU.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to KIRLPNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KIRLPNU.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, VESUVIUS.BO has a market cap of 97.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while VESUVIUS.BO trades at ₹482.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas VESUVIUS.BO's P/E ratio is 37.59. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to VESUVIUS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to VESUVIUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VESUVIUS.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, VESUVIUS.NS has a market cap of 97.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while VESUVIUS.NS trades at ₹482.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas VESUVIUS.NS's P/E ratio is 37.53. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to VESUVIUS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.BO is more volatile compared to VESUVIUS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check VESUVIUS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, DIACABS.NS has a market cap of 92.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while DIACABS.NS trades at ₹174.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas DIACABS.NS's P/E ratio is 87.81. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to DIACABS.NS's ROE of -0.12%. Regarding short-term risk, DIACABS.BO is less volatile compared to DIACABS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DIACABS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ISGEC.NS has a market cap of 80.4B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ISGEC.NS trades at ₹1,093.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ISGEC.NS's P/E ratio is 24.23. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ISGEC.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to ISGEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ISGEC.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ISGEC.BO has a market cap of 80.3B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ISGEC.BO trades at ₹1,092.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ISGEC.BO's P/E ratio is 24.18. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ISGEC.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to ISGEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ISGEC.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LLOYDSENGG.BO has a market cap of 79.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LLOYDSENGG.BO trades at ₹66.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LLOYDSENGG.BO's P/E ratio is 44.44. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LLOYDSENGG.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is less volatile compared to LLOYDSENGG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check LLOYDSENGG.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LLOYDSENGG.NS has a market cap of 79.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LLOYDSENGG.NS trades at ₹66.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LLOYDSENGG.NS's P/E ratio is 44.40. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LLOYDSENGG.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is less volatile compared to LLOYDSENGG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check LLOYDSENGG.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SHAKTIPUMP.NS has a market cap of 68.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SHAKTIPUMP.NS trades at ₹555.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SHAKTIPUMP.NS's P/E ratio is 26.44. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SHAKTIPUMP.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to SHAKTIPUMP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHAKTIPUMP.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SHAKTIPUMP.BO has a market cap of 68.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SHAKTIPUMP.BO trades at ₹555.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SHAKTIPUMP.BO's P/E ratio is 26.44. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SHAKTIPUMP.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to SHAKTIPUMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHAKTIPUMP.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, BALUFORGE.BO has a market cap of 60.2B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while BALUFORGE.BO trades at ₹528.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas BALUFORGE.BO's P/E ratio is 23.75. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to BALUFORGE.BO's ROE of +0.24%. Regarding short-term risk, DIACABS.BO is more volatile compared to BALUFORGE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check BALUFORGE.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, DIAPOWER.NS has a market cap of 52.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while DIAPOWER.NS trades at ₹195.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas DIAPOWER.NS's P/E ratio is -1.78. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to DIAPOWER.NS's ROE of +0.05%. Regarding short-term risk, DIACABS.BO is less volatile compared to DIAPOWER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check DIAPOWER.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LSIL.NS has a market cap of 52.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LSIL.NS trades at ₹48.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LSIL.NS's P/E ratio is 130.41. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LSIL.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.BO is more volatile compared to LSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LSIL.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TEXRAIL.NS has a market cap of 45.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TEXRAIL.NS trades at ₹111.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TEXRAIL.NS's P/E ratio is 25.37. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TEXRAIL.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEXRAIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEXRAIL.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, TEXRAIL.BO has a market cap of 45.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while TEXRAIL.BO trades at ₹111.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas TEXRAIL.BO's P/E ratio is 25.35. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to TEXRAIL.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.BO is more volatile compared to TEXRAIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check TEXRAIL.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, WPIL.BO has a market cap of 41.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while WPIL.BO trades at ₹425.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas WPIL.BO's P/E ratio is 34.85. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to WPIL.BO's ROE of +0.08%. Regarding short-term risk, DIACABS.BO is more volatile compared to WPIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check WPIL.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ANUP.NS has a market cap of 41.4B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ANUP.NS trades at ₹2,067.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ANUP.NS's P/E ratio is 36.09. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ANUP.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to ANUP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ANUP.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ANUP.BO has a market cap of 41.3B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ANUP.BO trades at ₹2,063.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ANUP.BO's P/E ratio is 35.94. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ANUP.BO's ROE of +0.19%. Regarding short-term risk, DIACABS.BO is more volatile compared to ANUP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ANUP.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, GREAVESCOT.BO has a market cap of 41.3B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while GREAVESCOT.BO trades at ₹177.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas GREAVESCOT.BO's P/E ratio is 39.83. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to GREAVESCOT.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to GREAVESCOT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GREAVESCOT.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, GREAVESCOT.NS has a market cap of 41.2B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while GREAVESCOT.NS trades at ₹177.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas GREAVESCOT.NS's P/E ratio is 38.25. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to GREAVESCOT.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.BO is more volatile compared to GREAVESCOT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GREAVESCOT.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, GMMPFAUDLR.BO has a market cap of 40.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while GMMPFAUDLR.BO trades at ₹891.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas GMMPFAUDLR.BO's P/E ratio is 226.31. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to GMMPFAUDLR.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to GMMPFAUDLR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GMMPFAUDLR.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, GMMPFAUDLR.NS has a market cap of 40.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while GMMPFAUDLR.NS trades at ₹891.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas GMMPFAUDLR.NS's P/E ratio is 226.81. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to GMMPFAUDLR.NS's ROE of +0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to GMMPFAUDLR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GMMPFAUDLR.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SHANTIGEAR.NS has a market cap of 34.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SHANTIGEAR.NS trades at ₹453.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SHANTIGEAR.NS's P/E ratio is 42.07. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SHANTIGEAR.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to SHANTIGEAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHANTIGEAR.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SHANTIGEAR.BO has a market cap of 34.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SHANTIGEAR.BO trades at ₹453.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SHANTIGEAR.BO's P/E ratio is 41.94. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SHANTIGEAR.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to SHANTIGEAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SHANTIGEAR.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SETL.NS has a market cap of 27.5B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SETL.NS trades at ₹137.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SETL.NS's P/E ratio is 36.54. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SETL.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.BO is more volatile compared to SETL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SETL.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, SGLTL.NS has a market cap of 27.4B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while SGLTL.NS trades at ₹137.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas SGLTL.NS's P/E ratio is 38.46. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to SGLTL.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to SGLTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check SGLTL.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KMEW.BO has a market cap of 26.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KMEW.BO trades at ₹2,197.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KMEW.BO's P/E ratio is 78.44. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KMEW.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.BO is less volatile compared to KMEW.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check KMEW.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, WINDMACHIN.NS has a market cap of 26.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while WINDMACHIN.NS trades at ₹305.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas WINDMACHIN.NS's P/E ratio is -954.69. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to WINDMACHIN.NS's ROE of -0.02%. Regarding short-term risk, DIACABS.BO is less volatile compared to WINDMACHIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check WINDMACHIN.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, WINDMACHIN.BO has a market cap of 26.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while WINDMACHIN.BO trades at ₹305.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas WINDMACHIN.BO's P/E ratio is -954.69. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to WINDMACHIN.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.BO is less volatile compared to WINDMACHIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check WINDMACHIN.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, JASH.NS has a market cap of 26.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while JASH.NS trades at ₹424.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas JASH.NS's P/E ratio is 48.06. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to JASH.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to JASH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check JASH.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, KLBRENG-B.BO has a market cap of 26.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while KLBRENG-B.BO trades at ₹506.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas KLBRENG-B.BO's P/E ratio is 27.20. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to KLBRENG-B.BO's ROE of +0.20%. Regarding short-term risk, DIACABS.BO is more volatile compared to KLBRENG-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check KLBRENG-B.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, HLEGLAS.BO has a market cap of 23.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while HLEGLAS.BO trades at ₹344.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas HLEGLAS.BO's P/E ratio is 35.26. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to HLEGLAS.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is more volatile compared to HLEGLAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HLEGLAS.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, HLEGLAS.NS has a market cap of 23.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while HLEGLAS.NS trades at ₹343.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas HLEGLAS.NS's P/E ratio is 35.19. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to HLEGLAS.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.BO is less volatile compared to HLEGLAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.BO.Check HLEGLAS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, HONDAPOWER.BO has a market cap of 23.2B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while HONDAPOWER.BO trades at ₹2,285.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas HONDAPOWER.BO's P/E ratio is 31.53. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to HONDAPOWER.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to HONDAPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HONDAPOWER.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, HONDAPOWER.NS has a market cap of 23.1B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while HONDAPOWER.NS trades at ₹2,278.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas HONDAPOWER.NS's P/E ratio is 31.48. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to HONDAPOWER.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to HONDAPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check HONDAPOWER.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, GMM.BO has a market cap of 22.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while GMM.BO trades at ₹1,563.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas GMM.BO's P/E ratio is 31.46. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to GMM.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to GMM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check GMM.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, PENIND.BO has a market cap of 22.7B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while PENIND.BO trades at ₹168.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas PENIND.BO's P/E ratio is 17.03. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to PENIND.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to PENIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PENIND.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, PENIND.NS has a market cap of 22.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while PENIND.NS trades at ₹167.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas PENIND.NS's P/E ratio is 16.96. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to PENIND.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.BO is more volatile compared to PENIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PENIND.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ADVAIT.BO has a market cap of 22.2B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ADVAIT.BO trades at ₹2,027.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ADVAIT.BO's P/E ratio is 48.67. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ADVAIT.BO's ROE of +0.23%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADVAIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADVAIT.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, PIXTRANS.BO has a market cap of 20.9B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while PIXTRANS.BO trades at ₹1,532.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas PIXTRANS.BO's P/E ratio is 19.09. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to PIXTRANS.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to PIXTRANS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PIXTRANS.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, PIXTRANS.NS has a market cap of 20.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while PIXTRANS.NS trades at ₹1,529.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas PIXTRANS.NS's P/E ratio is 19.05. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to PIXTRANS.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to PIXTRANS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check PIXTRANS.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, JNKINDIA.NS has a market cap of 20.7B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while JNKINDIA.NS trades at ₹370.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas JNKINDIA.NS's P/E ratio is 45.16. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to JNKINDIA.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to JNKINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check JNKINDIA.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, THEJO.NS has a market cap of 19.2B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while THEJO.NS trades at ₹1,766.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas THEJO.NS's P/E ratio is 39.35. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to THEJO.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to THEJO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check THEJO.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ADOR.NS has a market cap of 18.3B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ADOR.NS trades at ₹1,053.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ADOR.NS's P/E ratio is 22.35. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ADOR.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADOR.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ADOR.BO has a market cap of 18.3B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ADOR.BO trades at ₹1,052.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ADOR.BO's P/E ratio is 22.37. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ADOR.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADOR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADOR.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, DISAQ.BO has a market cap of 17.7B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while DISAQ.BO trades at ₹12,155.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas DISAQ.BO's P/E ratio is 33.28. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to DISAQ.BO's ROE of +0.20%. Regarding short-term risk, DIACABS.BO is more volatile compared to DISAQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check DISAQ.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, LXMIATO.BO has a market cap of 16.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while LXMIATO.BO trades at ₹2,483.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas LXMIATO.BO's P/E ratio is 584.15. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to LXMIATO.BO's ROE of +0.01%. Regarding short-term risk, DIACABS.BO is more volatile compared to LXMIATO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check LXMIATO.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, JYOTISTRUC.NS has a market cap of 15.7B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while JYOTISTRUC.NS trades at ₹13.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas JYOTISTRUC.NS's P/E ratio is 28.04. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to JYOTISTRUC.NS's ROE of +0.11%. Regarding short-term risk, DIACABS.BO is more volatile compared to JYOTISTRUC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check JYOTISTRUC.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, JYOTISTRUC.BO has a market cap of 15.7B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while JYOTISTRUC.BO trades at ₹13.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas JYOTISTRUC.BO's P/E ratio is 29.24. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to JYOTISTRUC.BO's ROE of +0.11%. Regarding short-term risk, DIACABS.BO is more volatile compared to JYOTISTRUC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check JYOTISTRUC.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ADORWELD.NS has a market cap of 14.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ADORWELD.NS trades at ₹852.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ADORWELD.NS's P/E ratio is 33.22. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ADORWELD.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADORWELD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADORWELD.NS's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, ADORWELD.BO has a market cap of 14.8B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while ADORWELD.BO trades at ₹852.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas ADORWELD.BO's P/E ratio is 24.67. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to ADORWELD.BO's ROE of +0.02%. Regarding short-term risk, DIACABS.BO is more volatile compared to ADORWELD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check ADORWELD.BO's competition here

DIACABS.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DIACABS.BO stands at 92.1B. In comparison, EKC.BO has a market cap of 13.6B. Regarding current trading prices, DIACABS.BO is priced at ₹174.80, while EKC.BO trades at ₹121.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DIACABS.BO currently has a P/E ratio of 87.84, whereas EKC.BO's P/E ratio is 14.08. In terms of profitability, DIACABS.BO's ROE is -0.12%, compared to EKC.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.BO is more volatile compared to EKC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.BO.Check EKC.BO's competition here